AKI Everywhere All at Once: Risks, Trajectories, and Practice Patterns
Back to course
Video Transcription
Video Summary
Asset Subtitle

Moderator(s): Javier Neyra, Gurmukteshwar Singh

Presentation(s):
  • Associations Between Sarcopenia, PhenoAgeAccel, and New-Onset AKI: A UK Biobank Study - Zhangzhe Peng
  • Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Kidney Dysfunction Independent of Diabetes and Hypertension: A Real-World Cohort Study Using TriNetX - Shori Gerardot
  • Relationship Between Environmental Temperature and Hospital Admissions for AKI from a US Electronic Health Records Database - Sarah Dixon Stump
  • Gene Signatures Predicting Kidney Function Trajectories After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome - Diangeng Li
  • KidneyPilot: Reinforcement Learning Model for Prevention of Persistent AKI After Cardiac Surgery - Moein Sabounchi
  • CRRT Utilization Trends and Economic Impact in AKI Patients Requiring Renal Replacement Therapy: A Nationwide Analysis - Benjamin Bizer
  • Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers During AKI Varies Substantially by Treatment Facility - Benjamin Griffin
  • Cystatin C Reveals Sex Differences in Misclassified Kidney Recovery and Undetected CKD Among AKI Survivors in ASSESS-AKI - Bethany Birkelo
  • Etiologies and Outcomes of Pregnancy-Related AKI in a US Quaternary Obstetric Population: A Retrospective Cohort Study - Mehdi Kashani

Note: Continuing education credits are not being offered for this session.
Meta Tag
Date 11/7/2025
Pathway 1 AKI and Critical Care
Session ID 519805
Keywords
acute kidney injury (AKI)
AKI risk factors
UK Biobank
sarcopenia
phenotypic age acceleration (phenoAgeAccel)
metabolic-associated steatotic liver disease (MASLD/MASH)
electronic health records (EHR)
ambient temperature and heat waves
machine learning prediction
PBMC gene expression biomarkers
reinforcement learning Kidney Pilot model
continuous renal replacement therapy (CRRT) outcomes
ACEi/ARB discontinuation during AKI